← Leaderboards
Brian Thomas Bateman
Brigham And Women'S Hospital
$6,450,805
Attributed
$10,060,808
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,060,808 · 4
By mechanism
R01$9,344,008 · 3
K08$716,800 · 1
Top collaborators
- Krista F Huybrechts11 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Krista F Huybrechts$10,039,261
- Seoyoung Catherine Kim$5,029,016
- Niteesh K Choudhry$10,267,534
- Katsiaryna Bykov$3,958,173
- S Bryn Austin$5,982,084
Others in their field
Top investigators on “Medicaid”
- David R. Weir · University Of Michigan At Ann Arbor$377,377,642
- Kenneth M Langa · University Of Michigan At Ann Arbor$32,850,148
- Stephen Crystal · Rutgers The St Univ Of Nj New Brunswick$30,600,942
- Reynold Alexander Panettieri · Rutgers Biomedical And Health Sciences$23,582,352
- Duane A. Mitchell · Duke University$22,945,544
- Vincent Mor · Brown University$22,578,425
Research focus
MedicaidPharmaceutical PreparationsPregnancyCohortSafetyWomanCongenital AbnormalityPremature BirthPregnant WomenPregnancy OutcomeAdverse Pregnancy OutcomeNeonatal OutcomeEpidemiologic MethodsSmall For Gestational Age InfantHigh RiskMothersPreventFirst Pregnancy TrimesterRelative RisksDiscipline Of ObstetricsOpioid UseDatabasesPostpartum PeriodDose
Grant awards (20)
The Comparative Effectiveness and Safety of Pharmacotherapies for the Treatment of Opioid Use Disorder in Pregnancy$763,288
R01 · FY2025 · DA
Safety of Benzodiazepines and Non-Benzodiazepine Sedative Hypnotics in Pregnancy$620,426
R01 · FY2025 · HD
The Comparative Effectiveness and Safety of Pharmacotherapies for the Treatment of Opioid Use Disorder in Pregnancy$839,898
R01 · FY2024 · DA
Safety of Benzodiazepines and Non-Benzodiazepine Sedative Hypnotics in Pregnancy$613,470
R01 · FY2024 · HD
The Comparative Effectiveness and Safety of Pharmacotherapies for the Treatment of Opioid Use Disorder in Pregnancy$688,134
R01 · FY2023 · DA
Safety of Benzodiazepines and Non-Benzodiazepine Sedative Hypnotics in Pregnancy$620,426
R01 · FY2023 · HD
The Comparative Effectiveness and Safety of Pharmacotherapies for the Treatment of Opioid Use Disorder in Pregnancy$688,134
R01 · FY2022 · DA
Safety of Benzodiazepines and Non-Benzodiazepine Sedative Hypnotics in Pregnancy$678,853
R01 · FY2022 · HD
The Comparative Effectiveness and Safety of Pharmacotherapies for the Treatment of Opioid Use Disorder in Pregnancy$701,082
R01 · FY2021 · DA
The Comparative Effectiveness and Safety of Pharmacotherapies for the Treatment of Opioid Use Disorder in Pregnancy$737,855
R01 · FY2020 · DA
The Impact of Prescription Opioid Use on Pregnancy Outcomes$460,858
R01 · FY2020 · DA · contact PI
Postpartum Opioid Related Mortality in Medicaid Patients$268,441
R01 · FY2020 · DA
The Impact of Prescription Opioid Use on Pregnancy Outcomes$546,546
R01 · FY2019 · DA · contact PI
The Impact of Prescription Opioid Use on Pregnancy Outcomes$546,546
R01 · FY2018 · DA · contact PI
The Impact of Prescription Opioid Use on Pregnancy Outcomes$570,051
R01 · FY2017 · DA · contact PI
Comparative safety & effectiveness of antihypertensive medications in pregnancy$168,160
K08 · FY2017 · HD · contact PI
Comparative safety & effectiveness of antihypertensive medications in pregnancy$137,160
K08 · FY2016 · HD · contact PI
Comparative safety & effectiveness of antihypertensive medications in pregnancy$137,160
K08 · FY2015 · HD · contact PI
Comparative safety & effectiveness of antihypertensive medications in pregnancy$137,160
K08 · FY2014 · HD · contact PI
Comparative safety & effectiveness of antihypertensive medications in pregnancy$137,160
K08 · FY2013 · HD · contact PI